Antibody design is one of the most exciting challenges in AI drug discovery. After Alphafold solved many of the problems of protein structure prediction, researchers moved their attention to protein structure design, and antibodies in particular are one of the most interesting proteins that we would like to design. Both because of the impact in patients as well as massive commercial potential. Join my chat with Santiago Mille from Stanford University about Germinal, a novel pipeline for antibody design.

Podden och tillhörande omslagsbild på den här sidan tillhör PAULING.AI. Innehållet i podden är skapat av PAULING.AI och inte av, eller tillsammans med, Poddtoppen.